TBC1D16 predicts chemosensitivity and prognosis in adult acute myeloid leukemia (AML) patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TBC1D16 predicts chemosensitivity and prognosis in adult acute myeloid leukemia (AML) patients

Published:2021-03 Issue: Volume:895 Page:173894
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Liu Han,Chen Peng,Yang Yong-Long,Zhu Ke-Wei,Wang Tao,Tang Ling,Liu Yan-Ling,Cao Shan,Zhou Gan,Zeng Hui,Zhao Xie-Lan,Zhang Wei,Chen Xiao-Ping

Funder

National Science and Technology Major Project

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology

Reference49 articles.

1. Adjuvant epigenetic therapy of decitabine and suberoylanilide hydroxamic acid exerts anti-neoplastic effects in acute myeloid leukemia cells;Abou Najem;Cells,2019

2. Prognostic factors in acute myeloid leukemia;Avivi;Curr. Opin. Hematol.,2005

3. Rab GEFs and GAPs;Barr;Curr. Opin. Cell Biol.,2010

4. Adaptation to TKI treatment reactivates ERK signaling in tyrosine kinase-driven leukemias and other malignancies;Bruner;Canc. Res.,2017

5. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia;Cancer Genome Atlas Research;N. Engl. J. Med.,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Novel DNA Methylation Prognostic Biomarkers for AML With Normal Cytogenetics;JCO Clinical Cancer Informatics;2024-07

2. RETRACTED ARTICLE: The predictive value of BTG1 for the response of newly diagnosed acute myeloid leukemia to decitabine;Clinical Epigenetics;2024-01-22

3. Abnormal regulation of miR-29b-ID1 signaling is involved in the process of decitabine resistance in leukemia cells;Cell Cycle;2023-04-09

4. Identifying Diagnostic and Prognostic Differentially Expressed Genes of Gastric Cancer Based on Bioinformatics Analyses of RNA-seq Data;Genetic Testing and Molecular Biomarkers;2022-11-01

5. Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives;Pharmaceutics;2022-03-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3